218 related articles for article (PubMed ID: 3517083)
1. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
Fontaine R; Chouinard G
J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine in the treatment of obsessive compulsive disorder.
Fontaine R; Chouinard G
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):605-8. PubMed ID: 3878975
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine treatment of obsessive-compulsive disorder.
Turner SM; Jacob RG; Beidel DC; Himmelhoch J
J Clin Psychopharmacol; 1985 Aug; 5(4):207-12. PubMed ID: 3894437
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder.
Frenkel A; Rosenthal J; Nezu A; Winston A
Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952
[TBL] [Abstract][Full Text] [Related]
6. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
Tollefson GD; Birkett M; Koran L; Genduso L
J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
[TBL] [Abstract][Full Text] [Related]
8. Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.
Levine R; Hoffman JS; Knepple ED; Kenin M
J Clin Psychopharmacol; 1989 Aug; 9(4):281-3. PubMed ID: 2504781
[TBL] [Abstract][Full Text] [Related]
9. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
Etain B; Bonnet-Perrin E
Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
[TBL] [Abstract][Full Text] [Related]
10. Obsessive compulsive disorder, depression, and fluoxetine.
Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
[TBL] [Abstract][Full Text] [Related]
11. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
Chouinard G
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
Wandzel L
Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
Byerley WF; Reimherr FW; Wood DR; Grosser BI
J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
[TBL] [Abstract][Full Text] [Related]
14. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
Sevincok L; Topuz A
J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
Bodfish JW; Madison JT
Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine treatment of children and adults with autistic disorder and mental retardation.
Cook EH; Rowlett R; Jaselskis C; Leventhal BL
J Am Acad Child Adolesc Psychiatry; 1992 Jul; 31(4):739-45. PubMed ID: 1644739
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
Kamijima K; Aoki M
Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
[TBL] [Abstract][Full Text] [Related]
19. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S
Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience.
Riddle MA; Hardin MT; King R; Scahill L; Woolston JL
J Am Acad Child Adolesc Psychiatry; 1990 Jan; 29(1):45-8. PubMed ID: 2295577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]